This is good research on a vaccine that is intended to reduce the clumping forms of alpha synuclein. This is an approach similar to Prasinezumab which is on track with promising results in later trials. Unlike Prasinezumab though this is presumably a one and done solution.
Too good to be true? Anyway, still a long way out.
insideprecisionmedicine.com...
The link above is regarding VAXXINITY. The link below is to do with PRASINEZUMAB monoclonal antibody :
it hasn't been proven that anti alpha synuclein is toxic?
That is what I have always thought. Do we really know what alpha synuclein does and so how does "vaccinating" against it affect other systems. However, there is the evidence from PRASINEZUMAB that the approach works. In addition, my reading is that the Vaxxinity antibodies are designed to "preferentially bind to the oligomeric and fibrillar forms of alpha-synuclein." Presumably this means the "bad" or abnormal alpha synuclein.
Alpha Synuclein: the problem or the byproduct? If the neurons are dead then why is it possible to improve? Revival? 
Parkinsons, DBS, Covid19 Pfizer Vaccine
The Latest in Efforts to Develop a Vaccine against Parkinson’s
PWP Covid Vaccine!!
Pfizer predicts vaccine by October.
